What proportion of alcohol and drug treatment episodes in Australia are amphetamine-related?

In 2012-13 there were 155,151 alcohol and other drug treatment episodes in Australia, of which 22,265 (14%) were related to amphetamines.

In 2012-13 in Australia, 41% (n=63,755) of all alcohol and other drug treatment episodes involved alcohol as the principal drug of concern, 24% (n=36,560) involved cannabis, 8% (n=12,817) involved heroin, 14% (n=22,265) involved amphetamines, and 13% (n=19,754) involved other drugs.

Source: Australian Institute of Health and Welfare 2014. Alcohol and Other Drug Treatment Services National Minimum Data Set 2012–13 (NCETA secondary analysis, 2014).

†Amphetamines are Central Nervous System (CNS) stimulants that increase neurotransmitter activity. Methamphetamine is a more potent form of amphetamine. The National Minimum Data Set does not provide data on methamphetamine use alone. Instead, treatment episodes due to methamphetamine use are subsumed within ‘amphetamines’. This category includes amphetamine, dexamphetamine, methamphetamine, amphetamine analogues, and amphetamines not elsewhere classified.

Principal Drug of Concern: The main substance that leads an individual to seek treatment from an alcohol and drug treatment agency (as stated by the individual).

Treatment Episode: A period of contact between a client and a treatment provider. Only ‘closed’ treatment episodes are included in the data used here. An episode is closed if there is a change in the principal drug of concern, main treatment, or service delivery setting; if the treatment ends; or if the patient is imprisoned or dies.